Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

aTYR Pharma INC

NASDAQ: ATYR · Life Sciences · 7 alerts · CIK 1339970

Share price
$5.24Close, Nov 16
Market cap
$13.4M
Shares outstanding
2.55MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All aTYR Pharma INC filings on SEC EDGAR ↗

4:02 PM ET 8-K
Nasdaq/NYSE Compliance Notice

aTYR Pharma Nasdaq/NYSE Compliance Notice

aTyr Pharma has regained compliance with Nasdaq's minimum bid price requirement after its common stock closed at or above $1.00 per share for 10 consecutive business days. The company had previously been under a deficiency notice since December 2025 and was granted an extension until November 30, 2026, to meet the standard. As of this filing, the company has no outstanding deficiency notices from Nasdaq.

Counterparty
Nasdaq
4:09 PM ET 8-K
Capital Raise

aTYR Pharma Capital Raise

aTyr Pharma, Inc. filed a prospectus supplement to establish an at-the-market (ATM) offering program for the sale of up to $79,994,251 of its common stock. The sales will be conducted through Jefferies LLC as the sales agent under an existing Open Market Sale Agreement. This filing allows the company to raise equity capital from time to time at prevailing market prices.

Counterparty
Jefferies LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.